Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2010
[Salpêtrière erythrophobia questionnaire validation].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pelissolo Antoine, Lobjoie Corine, Montefiore Delphine
Аннотация
OBJECTIVE: To study the main psychometric characteristics of the Salpêtrière Erythrophobia Questionnaire (SEQ) in a clinical and non-clinical sample.
METHOD: Patients with social phobia (SP) (n = 212), patients with other anxiety disorders (n = 146), and participants from the general population (n = 171) were distributed in the 3 study groups. They completed the SEQ as well as several anxiety and depression scales. Erythrophobia was diagnosed according to standardized criteria and assessed using the Clinical Global Impression Scale.
RESULTS: The SEQ scale factor pattern is clear, with only 1 factor explaining 83.9% of total score and a Cronbach's alpha consistency coefficient of 0.96. The SEQ score is significantly correlated to a dimensional hetero-evaluation of the fear of blushing (rho = 0.91) and SP measures (rho = 0.23 to 0.55). The SEQ mean score is higher in the SP group and even higher in the erythrophobia group. A score of 7 out of 24 makes it possible to identify erythrophobia with 92.1% sensitivity and 87.7% specificity. The SEQ test-retest reliability at 15-day interval is satisfactory (ICC = 0.83).
CONCLUSION: The SEQ is a valid and sensitive tool to screen and measure erythrophobia. It can be used in psychopathological and therapeutic studies of this pathology.
METHOD: Patients with social phobia (SP) (n = 212), patients with other anxiety disorders (n = 146), and participants from the general population (n = 171) were distributed in the 3 study groups. They completed the SEQ as well as several anxiety and depression scales. Erythrophobia was diagnosed according to standardized criteria and assessed using the Clinical Global Impression Scale.
RESULTS: The SEQ scale factor pattern is clear, with only 1 factor explaining 83.9% of total score and a Cronbach's alpha consistency coefficient of 0.96. The SEQ score is significantly correlated to a dimensional hetero-evaluation of the fear of blushing (rho = 0.91) and SP measures (rho = 0.23 to 0.55). The SEQ mean score is higher in the SP group and even higher in the erythrophobia group. A score of 7 out of 24 makes it possible to identify erythrophobia with 92.1% sensitivity and 87.7% specificity. The SEQ test-retest reliability at 15-day interval is satisfactory (ICC = 0.83).
CONCLUSION: The SEQ is a valid and sensitive tool to screen and measure erythrophobia. It can be used in psychopathological and therapeutic studies of this pathology.